Robert Weinstein Synaptogenix, Inc. (SNPX) insider trading activity

Robert Weinstein is Chief Financial Officer of Synaptogenix, Inc.. Currently has a direct ownership of 33,198 shares of SNPX, which is worth approximately $101,917. The most recent transaction as insider was on Dec 16, 2022, when has been sold 27,000 shares (Common Stock, par value $0.0001 per share) at a price of $1.17 per share, resulting in proceeds of $31,589. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 33.2K

0% 3M change

0% 12M change

Total Value Held $101,917

ROBERT WEINSTEIN Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Dec 16 2022	SELL Open market or private sale	$31,589 $1.17 p/Share	27,000 Reduced 44.85%	33,198 Common Stock, par valu...
Jul 13 2021	BUY Grant, award, or other acquisition	-	60,000 Added 49.92%	60,198 Common Stock, par valu...

Also insider at

XSPA

XpresSpa Group, Inc. Consumer Cyclical

Director

PMCB

PharmaCyte Biotech, Inc. Healthcare

Director